Hubbell Incorporated Reports Regular Quarterly Dividend GlobeNewswire July 25, 2025 Shelton, CT, July 25, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.32 per share on the Company's common stock. The dividend will be paid September 15, 2025 to shareholders of record on August […]
VCI Global Launches SecureGPU(TM) – First Encrypted AI Compute Server for Sovereign and Defense Applications SecureGPU(TM) Marks Milestone in Zero-Trust AI Infrastructure; Now Piloting Across Southeast Asia GlobeNewswire July 25, 2025 KUALA LUMPUR, Malaysia, July 25, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a diversified global holding company
(NASDAQ:CAPR), SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between October 9, 2024 and July 10, 2025. Capricor is a clinical-stage biotechnology company that engages in the development of transformative
CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action GlobeNewswire July 25, 2025 SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc.
In the news release, Elixir MD, Inc. Expands into Mexico Through Strategic Partnership with Dr. Leonardo Moreno-Tevizo and Dr. Andrés Bello Cárdenas to Launch the Innovative ELIXIR MD™ Device, issued 22-Jul-2025 by ELIXIR MD™ over PR Newswire, we are advised by the company that updates have been made. The complete, corrected release follows: ELIXIR MD,
(NasdaqGM:RXST), SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025. RxSight is a commercial-stage medical technology company, engaged in the research and development, manufacture,
RXST Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against RxSight, Inc. GlobeNewswire July 25, 2025 SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (NASDAQ: RXST) securities between November 7, 2024 and
(NYSE:BHVN), SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven is a biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience,
BHVN Class Action Alert: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Lead Plaintiff Deadline in the Class Action Against BHVN GlobeNewswire July 25, 2025 SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE:
Los Angeles, July 25, 2025 (GLOBE NEWSWIRE) — As kratom interest surges across the U.S. in 2025, Super Speciosa has relaunched its Watermelon Kratom Tincture with an enhanced, lab-verified formula, marking a key update in one of its most popular delivery formats. This revised tincture introduces improved alkaloid standardization, a smoother flavor profile, and a